Cargando…
Hepatitis C cross-genotype immunity and implications for vaccine development
While about a quarter of individuals clear their primary hepatitis C (HCV) infections spontaneously, clearance (spontaneous or treatment-induced) does not confer sterilizing immunity against a future infection. Since successful treatment does not prevent future infections either, an effective vaccin...
Autores principales: | Islam, Nazrul, Krajden, Mel, Shoveller, Jean, Gustafson, Paul, Gilbert, Mark, Wong, Jason, Tyndall, Mark W., Janjua, Naveed Zafar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615075/ https://www.ncbi.nlm.nih.gov/pubmed/28951612 http://dx.doi.org/10.1038/s41598-017-10190-8 |
Ejemplares similares
-
Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
por: Janjua, Naveed Zafar, et al.
Publicado: (2016) -
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016) -
Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants
por: Janjua, Naveed Zafar, et al.
Publicado: (2016) -
Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
por: Butt, Zahid A, et al.
Publicado: (2020) -
Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study
por: McKee, Geoffrey, et al.
Publicado: (2018)